# HT-ENDO: A Multiomics-based Biomarker for the Diagnosis of Endocrine Hypertension: a Pragmatic, Diagnostic, Randomized, Outcome-based Trial

> **NCT06578975** · NA · NOT_YET_RECRUITING · sponsor: **JDeinum** · enrollment: 250 (estimated)

## Conditions studied

- Hypertension

## Interventions

- **DIAGNOSTIC_TEST:** HT-ENDO-MOS-A13
- **OTHER:** Normal diagnosis

## Key facts

- **NCT ID:** NCT06578975
- **Lead sponsor:** JDeinum
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-11-01
- **Primary completion:** 2026-01-01
- **Final completion:** 2026-01-01
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2024-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06578975

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06578975, "HT-ENDO: A Multiomics-based Biomarker for the Diagnosis of Endocrine Hypertension: a Pragmatic, Diagnostic, Randomized, Outcome-based Trial". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06578975. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*